The Future is Now
“There are no major movements between firms, or any new firms popping up," says Petar Mitrovic, Partner at Karanovic & Partners in Belgrade, about the Serbian legal market. “There have been some movements, some partners leaving their law offices and moving to the private sector, but nothing worth writing home about."
Some might say that Serbia’s banking sector is blooming and steadily consolidating. Others may argue that actual consolidation is still far away. Either way, players on the local market are changing. This is clear now following the exit of Societe Genarale, BNP’s Findomestic, and two Greek banks, followed by the bold revamp of Hungary’s OTP and the strengthening of domestic investors such as AIK and Direktna Bank.
The wide usage of benchmark rates and their key role in the financial system requires that they be reliable and defiant to any manipulation. To ensure this, the EU undertook to reform the benchmark rate determination process and improve market confidence in them, resulting in the adoption of the EU Benchmarks Regulation (the BMR).
ODI Law has advised the Eta Invest Group on the refinancing of a development project encompassing 28 newly-constructed villas near Nova Gorica, Slovenia. The transaction included a transfer of claims held by various banking and non-banking entities to the Elements Capital Management investment fund, followed by the entrance into a Master Restructuring Agreement by Eta Invest Group and the investment fund. Karanovic & Partners advised Elements Capital Management.
This April, the new EU foreign investment screening regulation entered into force, with terms scheduled to become applicable on October 11, 2020. The regulation was conceived and designed to provide member states with a valuable tool to employ in defending their strategic interests. We spoke to several experts in the region to learn more.
BDK Advokati and Clifford Chance advised the EBRD, IFC, and the Development Bank of Austria on financing for a waste management public-private partnership project in the Vinca district of Belgrade. The City of Belgrade was advised by Hogan Lovells and Karanovic & Partners, with Karanovic & Partners also advising the IFC on the matter.
Pharmaceutical products have been in the spotlight of the Council of the European Union’s Product Liability Directive since its adoption in 1985. Despite the amount of time that has passed, some legal uncertainties remain that strike directly at the notion of defectiveness, as well as the causal link between the defect and the damage (which proved to be even more important in the case of pharmaceutical products). Establishing such causal link in cases involving vaccines is notoriously difficult, especially from the perspective of a lay consumer. This has led some EU member states, such as France, to introduce case law aimed at facilitating the burden of proof in specific sectors.